DK1697504T3 - Anvendelse af IL-6-type cytokiner til modning af oocytter - Google Patents

Anvendelse af IL-6-type cytokiner til modning af oocytter

Info

Publication number
DK1697504T3
DK1697504T3 DK04812306.1T DK04812306T DK1697504T3 DK 1697504 T3 DK1697504 T3 DK 1697504T3 DK 04812306 T DK04812306 T DK 04812306T DK 1697504 T3 DK1697504 T3 DK 1697504T3
Authority
DK
Denmark
Prior art keywords
type cytokines
mature oocytes
oocytes
mature
vitro
Prior art date
Application number
DK04812306.1T
Other languages
English (en)
Inventor
Ann M Clark
Matos Daniel Gustavo De
Jennifer A Jackson
Stephen S Palmer
Cam Anh T Tran
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34652319&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1697504(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of DK1697504T3 publication Critical patent/DK1697504T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/175—Cardiotrophin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2306—Interleukin-6 (IL-6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/237—Oncostatin M [OSM]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK04812306.1T 2003-11-26 2004-11-26 Anvendelse af IL-6-type cytokiner til modning af oocytter DK1697504T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52527903P 2003-11-26 2003-11-26
PCT/US2004/039757 WO2005054449A1 (en) 2003-11-26 2004-11-26 Use of il-6-type cytokines for maturation of oocytes

Publications (1)

Publication Number Publication Date
DK1697504T3 true DK1697504T3 (da) 2011-11-14

Family

ID=34652319

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10177394.3T DK2325201T3 (da) 2003-11-26 2004-11-26 Anvendelse af il-6-type-cytokiner til modning af oocytter
DK04812306.1T DK1697504T3 (da) 2003-11-26 2004-11-26 Anvendelse af IL-6-type cytokiner til modning af oocytter

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10177394.3T DK2325201T3 (da) 2003-11-26 2004-11-26 Anvendelse af il-6-type-cytokiner til modning af oocytter

Country Status (14)

Country Link
US (1) US8071375B2 (da)
EP (2) EP1697504B1 (da)
JP (1) JP5144073B2 (da)
AT (1) ATE521698T1 (da)
AU (1) AU2004294572A1 (da)
CA (1) CA2544409C (da)
DK (2) DK2325201T3 (da)
ES (2) ES2368846T3 (da)
HU (1) HUE031978T2 (da)
IL (1) IL175510A (da)
NO (1) NO341221B1 (da)
PL (2) PL1697504T3 (da)
PT (2) PT2325201T (da)
WO (1) WO2005054449A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA030000B9 (ru) * 2011-12-14 2018-09-28 Зе Боард Оф Трастиз Оф Зе Лилэнд Стэнфорд Джуниор Юниверсити Способ стимуляции развития зрелого ооцита
WO2016040493A1 (en) * 2014-09-10 2016-03-17 The Board Of Trustees Of The Leland Stanford Junior University Stimulation of ovarian follicle development and oocyte maturation
USRE50172E1 (en) 2014-12-19 2024-10-15 Vrije Universiteit Brussel In vitro maturation of a mammalian cumulus oocyte complex
CN113444683B (zh) * 2021-07-12 2022-11-04 华南农业大学 提高卵母细胞体外成熟质量的添加剂、培养方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5563059A (en) 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
WO1997030146A2 (en) * 1996-02-14 1997-08-21 Genentech, Inc. Cardiotrophin and uses therefor
ATE407363T1 (de) * 1998-06-22 2008-09-15 Medi Cult As Verfahren um den erfolg von einem auf in-vitro maturation (ivm) basierten verfahren zu vorhersagen
US6274135B1 (en) * 1999-06-22 2001-08-14 Genetics Institute, Inc. Method of using IL-11 for inflammation associated with acute pancreatitis
US6762053B2 (en) 2000-06-09 2004-07-13 Vitrolife, Inc. Mammalian gamete and embryo culture media and culture media supplements
AU2003208232B2 (en) * 2002-03-08 2008-05-22 Mcgill University In vitro maturation of immature human oocytes

Also Published As

Publication number Publication date
PT1697504E (pt) 2011-11-08
US20050142107A1 (en) 2005-06-30
PL2325201T3 (pl) 2017-05-31
CA2544409C (en) 2014-06-10
PT2325201T (pt) 2017-01-09
DK2325201T3 (da) 2017-02-20
US8071375B2 (en) 2011-12-06
CA2544409A1 (en) 2005-06-16
HUE031978T2 (en) 2017-08-28
NO20062949L (no) 2006-06-23
EP2325201A1 (en) 2011-05-25
PL1697504T3 (pl) 2012-01-31
ES2610161T3 (es) 2017-04-26
EP1697504A1 (en) 2006-09-06
IL175510A (en) 2011-03-31
WO2005054449A1 (en) 2005-06-16
JP2007535303A (ja) 2007-12-06
NO341221B1 (no) 2017-09-18
AU2004294572A1 (en) 2005-06-16
ATE521698T1 (de) 2011-09-15
JP5144073B2 (ja) 2013-02-13
EP2325201B1 (en) 2016-11-09
EP1697504B1 (en) 2011-08-24
ES2368846T3 (es) 2011-11-22
IL175510A0 (en) 2006-09-05

Similar Documents

Publication Publication Date Title
BR0309492A (pt) Uso de pelo menos um álcool ramificado alcoxilado
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
DK2308418T3 (da) Flowcytometridyse for tilvejebringelse af kønssorteret dyresæd
DK2275413T3 (da) 2,4-di(phenylamino)-pyrimidiner egnede til behandlingen af neoplastiske sygdomme, inflammatoriske og immunsystem lidelser.
EA200801663A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1'-(1-МЕТИЛЭТИЛ)-4'-[(2-ФТОР-4-МЕТОКСИФЕНИЛ)МЕТИЛ]-5'-МЕТИЛ-1H-ПИРАЗОЛ-3'-O-β-D-ГЛЮКОПИРАНОЗИДА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
CR7977A (es) Anilidas de acido trifluorometil-tiofencarboxilico y su uso como fungicidas
DE602004030334D1 (de) Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen
EA200200590A1 (ru) Производные пирролидина в качестве ингибиторов фосфодиэстеразы, специфичной к циклическому амф
CY1107846T1 (el) Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες
CR8475A (es) Fenilalanina-amidas sustituidas por benzoilo
CR8640A (es) Proceso para producir un compuesto de 5-hidroxi-4-tiometilpirazol
DK1730313T3 (da) Forøget proteinekspressionsudbytte i cellefri proteinsyntesesystemer ved tilsætning af skumdæmpende midler
IL178156A0 (en) Intermediates for the preparation of pramipexole
ATE557082T1 (de) Sequenz positionen zur anpassung bei prrsv
DE602004026917D1 (de) Basalmedium zur kultivierung von es-zellen
DK1697504T3 (da) Anvendelse af IL-6-type cytokiner til modning af oocytter
ATE373645T1 (de) Phenyltetrazol-verbindungen
EA200301105A1 (ru) 5-галоген-6-фенил-7-фторалкиламинотриазолпиримидины
GT200600251A (es) Intermediarios utiles en la sintesis de moduladores de alquilquinolina y alquilquinazolina quinasa y metodos de sintesis relacionados.
EA200300520A1 (ru) Способ получения кристаллического моногидрата n-формимидоилтиенамицина (моногидрата имипенема)
ITMI20030578A1 (it) Processo ed intermedi per la preparazione di emtricitabina
BRPI0514584A (pt) método para preparar irbesartan e intermediários do mesmo
BR0009453B1 (pt) processo para a preparação de um composto.
DK1480998T3 (da) Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
BRPI0411751A (pt) processo de polimerização para preparação de